You are here: Home > Animal Drugs > A > Amprol 25 (Huvepharma, Inc.)|
NADA 12-350 Product 956150
of coccidiosis in growing chickens, turkeys and pheasants and (2) development
of active immunity to coccidiosis in replacement chickens. AMPROL 25% is also
intended for use in the prevention and treatment of coccidiosis in laying chickens.
ACTIVE DRUG INGREDIENT: Amprolium ......25%
Ingredients: Corn Gluten Feed and Soybean Oil
SEE DIRECTIONS ON BACK PANEL
Manufactured by: Huvepharma, Inc.
Huvepharma, Inc., St. Louis, MO 63116 525 Westpark Drive, Suite 230
Peachtree City, GA 30269
Huvepharma, Inc., Peachtree City, GA 30269
AMPROL is a registered trademark of Huvepharma, Inc.
Net Wt.: 50 lb (22.68 kg)
AMPROL (amprolium) 25% should be thoroughly and evenly mixed in the feed. AMPROL 25% may be used to manufacture a
In Type C Medicated Feed AMPROL 25% Per Ton
0.004 % 5 oz
0.006% 8 oz
0.008% 10 oz
0.0125% 1 lb
0.0175% 1 lb 61/2 oz
0.025% 2 lb
AMOUNT AND DIRECTIONS FOR USE
Broilers: Prevention: Use 0.0125% amprolium Type C medicated feed continuously for most field conditions
as they exist under modern management practices. Where severe coccidiosis conditions exist
and where immunity is not required, use 0.025% amprolium Type C medicated feed. For field
conditions where only E. tenella is the major problem, use 0.008%-0.0125% amprolium
Type C medicated feed.
Increasing levels of amprolium may not prevent coccidiosis caused by strains of Eimeria
commonly found to be resistant to amprolium.
Replacements: Immunity Development or Prevention
Prevention Program: Where immunity development is not desirable, use 0.0125%-0.025% amprolium Type C
medicated feed continuously from day old until onset of production.
Program: Use 0.004%-0.0125% amprolium Type C medicated feed continuously until onset of production.
Selection of the level to be used should be based upon comparative hazard of infection with cecal and intestinal species. The higher
levels will interfere with the development immunity to E. tenella (cecal).
The following are suggested feeding schedules for various conditions of coccidial exposure. The planning and evaluation of any
program should be in the hands of a veterinarian or poultry pathologist who is familiar with the specific operation and
with the general nature of disease problems in the area.
1. Severe exposure 2. Moderate exposure 3. Slight exposure
0-5 weeks of age 0.0125% 0-5 weeks of age 0.008%--0.0125% 0-5 weeks of age 0.004%-0.0125%
5-8 weeks of age 0.008%-0.0125% 5-8 weeks of age 0.006%-0.0125% 5-8 weeks of age 0.004%-0.0125%
Over 8 weeks of age 0.004%-0.0125% over 8 weeks of age 0.004%-0.0125% over 8 weeks of age 0.004%-0.0125%
LAYING CHICKENS:Treatment: Use 0.025% amprolium Type C medicated feed for two weeks in severe outbreaks
or 0.0125% amprolium Type C medicated feed for two weeks in moderate outbreaks.
Prevention: Use 0.0125% amprolium Type C medicated freed continuously
TURKEYS: Prevention: Use 0.0125%-0.025% amprolium Type C medicated feed continuously.PHEASANTS: For the prevention of coccidiosis in growing pheasants caused by Eimeria colchici,
E. duodenalis, and E. phasiani.
Type C medicated feed with 0.0175% amprolium should be fed continuously as the sole ration.
CAUTIONUse as the sole source of amprolium.
Do not change the litter while giving this feed unless absolutely necessary.
If losses exceed 0.5% in a 2-day period, obtain an accurate diagnosis, and follow the instructions of your veterinarian or poultry
Losses may result from intercurrent disease or other conditions affecting drug intake which can contribute to the virulence of
coccidiosis under field conditions.
In replacement flocks the grower must expect that excessive exposure to one or more species may overwhelm the drug in some
flocks and prompt treatment will be required.
Fertility, hatchability and other reproductive data are not available on amprolium in breeding pheasants.
Do not use in feeds containing bentonite.
Restricted Drug (California) Use Only as Directed.
Revised: 05/2011 Huvepharma, Inc.
Reproduced with permission of U.S. National Library of Medicine
Copyright © 2017
|Over-the-counter (OTC) Drugs|